Clinical trial
Levetiracetam Treatment of Children With Subclinical Sleep-Activated…
NCT00393614 · Oslo University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00393614 |
|---|---|
| Title | Levetiracetam Treatment of Children With Subclinical Sleep-Activated Epileptiform Activity (SSEA) |
| Official title | Levetiracetam Treatment of Children With Subclinical Sleep-Activated Epileptiform Activity (SSEA) - a Placebo Controlled Double-blind Cross-over-study |
| Lead sponsor | Oslo University Hospital, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Subclinical Sleep-Activated Epileptiform Activity, CSWS |
| Intervention type | Drug |
| Interventions | levetiracetam |
| Enrollment | 30 |
| Start date | May 1, 2007 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Oct 30, 2006 |
| Last update posted | Sep 23, 2009 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: